Drawing for CANARE

USPTO serial 90904698

CANARE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ROCHA, CAMERON R
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CANARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kevin S. Costanza

Kevin S. Costanza SEED IP LAW GROUP LLP701 FIFTH AVENUESUITE 5400SEATTLE, WA 98104

Goods and services

ClassDescriptionStatusFirst use
009Recorded computer software for the collection, organization, storage and transmission of data and information from artificial orthopedic implants and wearable medical devices; recorded computer programs for analyzing medical and scientific data from implantable and wearable medical devicesACTIVE—
010Wearable medical devices for monitoring and recording kinematic data; medical devices and apparatus, namely, systems for monitoring and recording kinematic data for medical purposes consisting primarily of an artificial orthopedic implant, a wearable medical device, and recorded computer software for providing kinematic data and information to medical professionals, sold as a unitACTIVE—
035Collection, handling and management of data, namely, compilation of information from implantable and wearable medical devices into computer databases and management of related business information in the field of medicineACTIVE—
042Providing temporary use of on-line non-downloadable computer software for the collection, organization, storage and transmission of data and information from the implant and the wearable medical device and for analyzing medical and scientific data from implantable and wearable medical devices; platform as a service (PAAS) featuring computer software platforms for the collection, organization, storage and transmission of data and information from the implant and the wearable medical device and for analyzing medical and scientific data from implantable and wearable medical devicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 22, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 22, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 4, 2025EX5GSOU EXTENSION 5 GRANTED—
Jun 3, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 18, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 17, 2025EXT5SOU EXTENSION 5 FILED—
Aug 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 13, 2024EX4GSOU EXTENSION 4 GRANTED—
Aug 13, 2024EXT4SOU EXTENSION 4 FILED—
Aug 13, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 9, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 7, 2024EX3GSOU EXTENSION 3 GRANTED—
Feb 7, 2024EXT3SOU EXTENSION 3 FILED—
Feb 7, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 15, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 13, 2023EX2GSOU EXTENSION 2 GRANTED—
Aug 13, 2023EXT2SOU EXTENSION 2 FILED—
Aug 13, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 18, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 16, 2023EX1GSOU EXTENSION 1 GRANTED—
Feb 16, 2023EXT1SOU EXTENSION 1 FILED—
Feb 16, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 16, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 21, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 21, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 1, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 18, 2022PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 17, 2022ALIEASSIGNED TO LIE—
May 11, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 19, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 6, 2021DOCKASSIGNED TO EXAMINER—
Oct 6, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 30, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance